Tuesday, April 02, 2013 5:49:14 PM
Ivivi:
Regenesis, who goes to great lengths to explain the difference between IMJ and ILX.
http://www.regulations.gov/#!documentDetail;D=FDA-2012-N-0378-0017
Anyways, there are obviously two different topics being discussed:
1) Is BIEL's product incorrectly classified, which is being addressed in their specific petitions to their 510K rejections. Personally I don't think this is a valid argument, but I'm no scientist.
2) Should ALL diathermy "non-thermal" devices be classified as Class III requiring a PMA (the FDAs proposal), reclassified as Class II devices requiring special controls (which the manufacturers obviously want), or left as they are. This is the topic that was supposed to be addressed at the FDA meeting. Who knows when they'll get back around to it now?
Good discussion today guys, I enjoyed it.
Alliance Creative Group (ACGX) Releases Q3 2024 Financial and Disclosure Report with an increase of over 100% in Net Income for 1st 9 months of 2024 vs 2023 • ACGX • Nov 14, 2024 8:30 AM
Unitronix Corp. Publishes Its Cryptocurrency Portfolio Strategy • UTRX • Nov 14, 2024 8:05 AM
Avant Technologies and Ainnova Tech Form Joint Venture to Advance Early Disease Detection Using Artificial Intelligence • AVAI • Nov 12, 2024 9:00 AM
Swifty Global Announces Launch of Swifty Sports IE, Expanding Sports Betting and Casino Services in the Irish Market • DRCR • Nov 12, 2024 9:00 AM
Oohvie App Update Enhances Women's Health with Telemedicine and Online Scheduling • HLYK • Nov 11, 2024 8:00 AM
SANUWAVE Announces Record Quarterly Revenues: Q3 FY2024 Financial Results • SNWV • Nov 8, 2024 7:07 AM